Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.34 |
| ▸ | PGR | P06401 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.34 |
| ▸ | HTR1A | P08908 | 1/20 | 0.34 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.34 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.34 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.34 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.34 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.34 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8415220 | 0.91 | CA2 (0.42) | CA2ALDH1A1HSD17B10LMNAKDM4E | |
| SCHEMBL14192901 | 0.91 | CA2 (0.42) | CA2ALDH1A1HSD17B10LMNAKDM4E | |
| SCHEMBL8418054 | 0.91 | CA2 (0.42) | CA2ALDH1A1HSD17B10LMNAKDM4E | |
| SCHEMBL7593762 | 0.89 | CA2 (0.41) | CA2ALDH1A1HSD17B10LMNAKDM4E | |
| SCHEMBL7595385 | 0.85 | CA2 (0.41) | CA2ALDH1A1HSD17B10LMNAKDM4E | |
| SCHEMBL9685052 | 0.77 | ALDH1A1 (0.50) | CA2ALDH1A1HSD17B10LMNAKDM4E | |
| SCHEMBL4168639 | 0.77 | ALDH1A1 (0.50) | CA2ALDH1A1HSD17B10LMNAKDM4E | |
| SCHEMBL6227052 | 0.76 | LMNA (0.37) | CA2ALDH1A1LMNACHRM1TBXA2R | |
| SCHEMBL7594746 | 0.75 | CA2 (0.34) | CA2ALDH1A1 | |
| SCHEMBL13034117 | 0.75 | ALDH1A1 (0.48) | CA2ALDH1A1HSD17B10LMNAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230321284-A1 | COMPOUND, CONTRAST AGENT, AND METHOD FOR PRODUCING COMPOUND | ST. MARIANNA UNIVERSITY SCHOOL OF MEDICINE (JP) | 2023-10-12 | — | — | US | disclosed |
| US-7355067-B2 | Process for the production of triiodotrimesic acid | SCHERING AG (DE) | 2008-04-08 | — | — | US | disclosed |
| US-7355067-B2 | Process for the production of triiodotrimesic acid | SCHERING AG (DE) | 2008-04-08 | — | — | US | disclosed |
| US-20070093674-A1 | Process for the production of triiodotrimesic acid | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-04-26 | — | — | US | disclosed |
| US-20070093674-A1 | Process for the production of triiodotrimesic acid | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-04-26 | — | — | US | disclosed |
| US-7166740-B2 | Process for the production of triiodotrimesic acid | SCHERING AG (DE) | 2007-01-23 | — | — | US | disclosed |
| US-7166740-B2 | Process for the production of triiodotrimesic acid | SCHERING AG (DE) | 2007-01-23 | — | — | US | disclosed |
| US-6448442-B1 | X-RAY CONTRAST AGENTS; LOW VISCOSITY IODINATED ARYL COMPOUNDS | AMERSHAM HEALTH AS (NO) | 2002-09-10 | — | — | US | disclosed |
| US-6310243-B1 | BENZENE COMPOUNDS IN WHICH 3 NON-ADJACENT RING ATOMS ARE SUBSTITUTED WITH IODINE, 2 OF THE REMAINING RING ATOMS ARE AMIDE SUBSTITUTED WITH HYDROXY AND THE OTHER REMAINING RING ATOM IS A NON-AMIDE, HYDROXY-SUBSTITUTED NONIONIC MOIETY | NYCOMED IMAGING AS (NO) | 2001-10-30 | — | — | US | disclosed |
| US-5993780-A | A POLYIODOARYLALKYL ALCOHOL OR DERIVATIVE | NYCOMED IMAGING AS (NO) | 1999-11-30 | — | — | US | disclosed |
| US-5882628-A | Contrast media | NYCOMED IMAGING AS (NO) | 1999-03-16 | — | — | US | disclosed |
| EP-0782564-A1 | IODINATED X-RAY CONTRAST MEDIA | NYCOMED IMAGING AS (NO) | 1997-07-09 | — | — | EP | disclosed |
| WO-1996009282-A1 | IODINATED X-RAY CONTRAST MEDIA | NYCOMED IMAGING A/S (NO) | 1996-03-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070093674-A1 | Process for the production of triiodotrimesic acid | TRHDE, TRHR, TSHR | CA2 556/4885ALDH1A1 3838/4885HSD17B10 1826/4885 |
| US-20230321284-A1 | COMPOUND, CONTRAST AGENT, AND METHOD FOR PRODUCING COMPOUND | RXFP1, AVPR2, RXFP3 | CA2 361/4885ALDH1A1 2641/4885HSD17B10 4298/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.